Signaling Pathways in Cancer: Ras and Wnt

Signaling Pathways in Cancer: Ras and Wnt

Learning Objectives

  • Understand biochemical activation of Ras

  • Identify the functions of Src Homology domains (SH1, SH2, SH3)

  • Explain diversity in cell responses resulting from ligand-receptor binding

  • Detail Ras-regulated and Wnt-regulated signaling pathways

  • Discuss the role of these pathways in cancer

Overview of Content

  • Ras upstream stimulator (Sos)

  • Src homology domains (SH1, SH2, SH3)

  • Ras-regulated signaling pathways

  • PI3K signaling pathway

  • Wnt–β-catenin pathway

Ligand-Receptor Binding and Cell Behavior

  • Binding activates tyrosine kinase domains, leading to cellular changes.

  • Key receptors: EGF, insulin, FGF, PDGF, which interact via immunoglobulin-like and cysteine-rich domains.

Ras Protein and Signaling Cascade

  • Ras acts as a binary switch, mediating complex signaling events.

  • Sos is a Guanine nucleotide exchange factor (GEF) that activates Ras by facilitating GDP release.

Src Homology Domains (SH)

  • SH1: Catalytic, found in receptor tyrosine kinases (RTKs).

  • SH2: Acts as intracellular receptors, binding specific phosphotyrosine-containing oligopeptides.

  • SH3: Binds to proline-rich sequences in partner proteins.

SH2 Domain Functionality

  • Each distinct SH2 domain is unique to different proteins, allowing for specific ligand binding and interaction.

  • Regulatory roles in signal transduction by positioning proteins near their activation sites.

Phosphorylation and Signaling Intermediates

  • Ligand-receptor binding causes transphosphorylation of receptor's cytoplasmic domains.

  • Phosphotyrosine residues form binding sites for SH2 domain-containing proteins (e.g., Ras-GAP, PI3K).

Ras-Regulated Signaling Pathways I

  • MAPK Pathway: Ras → Raf → MEK → ERK1/2 leads to gene expression regulation.

  • In cancers, B-Raf may become hyperactive in absence of Ras.

Ras-Regulated Signaling Pathways II: The PI3K Pathway

  • Main function: Suppress apoptosis via Akt/PKB and stimulate cell growth via mTOR.

  • PI3K mechanism: Converting PIP2 to PIP3, which is crucial for Akt activation.

The Wnt–β-Catenin Pathway

  • Regulates cell proliferation and maintains undifferentiated states via Wnt factors.

  • In cancer, β-catenin translocates to the nucleus, affecting transcription.

Cancer Implications of Wnt–β-Catenin Pathway

  • Increased Wnt expression in various cancers; mutations in β-catenin impact phosphorylation and signaling.

  • Impaired degradation processes of β-catenin in several cancers (e.g., colon carcinomas due to Apc defects).

Conclusion

  • Both Ras and Wnt pathways are integral to understanding cancer biology and therapeutic targets.

Questions?

  • Discuss any uncertainties or need for clarification regarding the material covered.

Learning Objectives

  • Understand the biochemical activation of Ras, including the role of various upstream activators and downstream effectors.

  • Identify the functions of Src Homology domains (SH1, SH2, SH3) and their significance in intracellular signaling.

  • Explain the diversity in cell responses resulting from ligand-receptor binding, including specificity and cross-talk between pathways.

  • Detail the mechanisms of Ras-regulated and Wnt-regulated signaling pathways and their interactions in cellular processes.

  • Discuss how alterations in these pathways contribute to cancer development and progression, with examples from different cancer types.

Overview of Content

  • Ras upstream stimulator (Sos) and its mechanism of action in the activation of Ras.

  • Detailed functions of Src homology domains (SH1, SH2, SH3) and their interactions within signaling networks.

  • A comprehensive review of Ras-regulated signaling pathways, including the MAPK and PI3K pathways and their roles in cell survival and proliferation.

  • The Wnt–β-catenin pathway, its regulatory mechanisms, and impact on cell fate decisions during development and in cancer.

Ligand-Receptor Binding and Cell Behavior

  • Ligand binding activates receptor tyrosine kinases (RTKs) through dimerization or conformational changes, resulting in the activation of intrinsic tyrosine kinase activity, leading to autophosphorylation of tyrosine residues

  • Key receptors involved in this process include EGF (Epidermal Growth Factor), insulin, FGF (Fibroblast Growth Factor), and PDGF (Platelet-Derived Growth Factor), which interact via specific structural domains, namely immunoglobulin-like and cysteine-rich domains, facilitating diverse intracellular signaling cascades.

Ras Protein and Signaling Cascade

  • Ras functions as a binary switch that can toggle between an inactive GDP-bound state and an active GTP-bound state, mediating a multitude of signaling pathways.

  • Sos (Son of Sevenless) acts as a Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP on Ras, thus activating it. The activation of Ras is pivotal for the initiation of signaling cascades that affect cell growth, differentiation, and survival.

Src Homology Domains (SH)

  • SH1: Catalytic domain found in receptor tyrosine kinases (RTKs), responsible for the intrinsic kinase activity, which phosphorylates tyrosine residues on substrates, propagating the signal downstream.

  • SH2: Binds specifically to phosphotyrosine-containing oligopeptides, facilitating the recruitment of signaling proteins to sites of activation on the receptor, thus contributing to the specificity of signaling events.

  • SH3: Binds to proline-rich sequences in partner proteins, playing a critical role in protein-protein interactions and the formation of multiprotein signaling complexes which enhance signal transduction efficiency.

SH2 Domain Functionality

  • The unique structure and sequence of each SH2 domain allow it to bind to specific phosphotyrosine-containing proteins, providing a means of signaling specificity.

  • These domains play critical regulatory roles in signal transduction, ensuring that proteins are precisely localized to their sites of action and enhancing the efficiency and specificity of signaling pathways through spatial organization.

Phosphorylation and Signaling Intermediates

  • Ligand-receptor binding leads to transphosphorylation of the receptor's cytoplasmic domains, creating phosphotyrosine residues. These residues serve as docking sites for proteins containing SH2 domains, such as Ras-GAP (GTPase-activating protein) and PI3K (Phosphoinositide 3-kinase), further propagating the signal.

Ras-Regulated Signaling Pathways I

  • MAPK Pathway: The pathway is initiated by Ras, activating Raf, subsequently leading to MEK (Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase) which phosphorylates ERK1/2 (Extracellular Signal-Regulated Kinases). Activated ERK1/2 translocates to the nucleus to regulate gene expression responsible for progression through the cell cycle. Hyperactivity of B-Raf in the absence of Ras is often implicated in various cancers, promoting uncontrolled cell proliferation.

Ras-Regulated Signaling Pathways II: The PI3K Pathway

  • The PI3K pathway primarily functions to suppress apoptosis, promote cell survival, and stimulate cell growth through the Akt/PKB (Protein Kinase B) pathway and mTOR (mammalian Target of Rapamycin) signaling.

  • The mechanism involves converting phosphatidylinositol 4,5-bisphosphate (PIP2) into phosphatidylinositol 3,4,5-trisphosphate (PIP3), which is critical for the activation of Akt and subsequent downstream signaling that facilitates cellular growth and survival.

The Wnt–β-Catenin Pathway

  • The Wnt signaling pathway plays a crucial role in regulating cell proliferation and maintaining pluripotent states in stem cells through Wnt ligands that bind to Frizzled receptors, leading to stabilization of β-catenin in the cytoplasm.

  • In cancer, aberrant activation of this pathway leads β-catenin to translocate to the nucleus, where it influences transcription of genes associated with cell growth and invasion, contributing to cancer pathogenesis.

Cancer Implications of Wnt–β-Catenin Pathway

  • Increased expression of Wnt ligands has been noted in various cancers, and mutations in β-catenin disrupt the phosphorylation process, allowing for continued signaling without regulation.

  • The pathways linking impaired phosphorylation and signaling are pivotal in several cancers, particularly colon carcinomas linked to defects in the Apc (Adenomatous polyposis coli) tumor suppressor gene that normally targets β-catenin for degradation.

Conclusion

  • Understanding both Ras and Wnt signaling pathways is integral to deciphering cancer biology, identifying potential therapeutic targets, and developing interventions aimed at disrupting these oncogenic signaling cascades. Research continues to unearth the complexities of these pathways, highlighting their roles in cancer progression and treatment response